We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Single-Use Biocontainers Reduce Biotech Manufacturing Problems

By LabMedica International staff writers
Posted on 12 Feb 2009
Some of the problems of biotech manufacture have been alleviated with the recent introduction of a line of high quality, single-use biocontainers.

A new line of single-use biocontainers offers significant advantages over reusable stainless steel containers. More...
Produced in 100 to 500-liter sizes, the biocontainers are made from a proprietary polymeric film designed to meet critical performance requirements associated with biotechnology and biopharmaceutical manufacturing. The film comprises inert polyethylene inner and outer layers that sandwich between them a gas-barrier film interlayer of ethylene vinyl alcohol polymer. This ensures that the biocontainers possesses excellent gas barrier properties with high clarity and flexibility. The containers are compatible with a wide range of chemicals, have very low level of leachables, and contain no animal derived ingredients.

Called the Allegro 3D, the biocontainer offers many possible applications, among them cell culture media preparation and storage, buffer preparation and storage, product and cell harvesting, intermediate product storage, and bulk product storage prior to filling.

The Alegro 3D biocontainer from by Pall Life Sciences (East Hill, NY, USA) hosts a sophisticated series of access ports for easy filling, emptying, and monitoring. A stainless steel "tote" or lockable cabinet is used to house the biocontainer in the optimum configuration for complete emptying, and an optional stainless steel trolley is available to help move filled biocontainers around the manufacturing facility.

"Single-use disposable technology is a proven alternative solution for the biotech and biopharm industries, …” said Dr. Helene Pora, senior director of single-use systems at Pall Life Sciences. "Single-use systems provide a greater assurance of sterility and purity by reducing microbial and cross contamination risks. They also reduce capital investment costs for facilities and equipment, costs associated with cleaning and cleaning validation, and they reduce lead times to help get drug products to market faster. In applications that process hazardous materials, such as cytotoxic drugs and potent biological materials, closed disposable systems offer additional protection by isolating operators from potential dangers."

Related Links:
Pall Life Sciences



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.